Yuan Xi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yuan Xi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Gang Zhou
School of Biological Science and Medical Engineering, Beihang University, Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, Beijing 100083, China
2 shared publications Hong Liu
Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education School of Biological Science and Medical Engineering China Tobacco Guangxi Industrial Co.LTD South Beihu Guangxi China
1 shared publication- Qing Li
Center of Digital Dentistry, Peking University School and Hospital of Stomatology, Beijing, China
1 shared publication Tianhui Huang
Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education School of Biological Science and Medical Engineering China Tobacco Guangxi Industrial Co.LTD South Beihu Guangxi China
1 shared publication- Tong Wang
National Engineering Laboratory for Digital and Material Technology of Stomatology, 22 Zhongguancun Nandajie, Haidian District, Beijing, 100081, China
1 shared publication - Xin Yu
Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, School of Biological Science and Medical Engineering, Beihang University, Beijing, 100191, China
1 shared publication
Latest Publications
- Open Access
- 9 December 2016
- Published by Atlantis Press SARL
Preparation and Characterization of a Novel Absorber for Formaldehyde
- 9 December 2016
- Published by Atlantis Press SARL
Open AccessPreparation and Characterization of a Novel Absorber for Formaldehyde
- Open Access
- 15 April 2015
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 14 (1) , 33
Porous deproteinized bovine bone scaffold with three-dimensional localized drug delivery system using chitosan microspheres
Bone substation grafts, such as hydroxyapatite (HA) and tricalciumphosphate (TCP), have been extensively used in clinical applications, but evidence suggests that they offer poor osteoinductive properties compared to allografts and autografts. In order to increase bone growth with such grafts, Bone Morphogenetic Protein 2 (BMP-2) was incorporated into a three dimensional reservoir. The purpose of the present study was to develop a novel drug delivery system which is capable of controlled release of BMP-2. DBB were prepared from bovine cancellous bone harvested from fetal bovine femur or tibia and then sinting at 1000°C. BMP-2-loaded chitosan (CS) microspheres were fabricated by cross-linking. Then the treated DBB powders were blended with chitosan microspheres solution. Finally, the composites were lyophilized with a freeze dryer to obtain the DBB/CMs scaffolds. X-ray diffractor (XRD), scanning electron microscopy (SEM) and Fourier transform infrared (FT-IR) were used to characterize the sample. The quantification of the delivery profile of BMP-2 was determined using an enzyme-linked immunosorbent assay (ELISA) kit. The in vitro assays were to characterize the biocompatibility of this composite. In this study, BMP-2/Chitosan (CS) microspheres were successively loaded onto a deproteinized bovine bone (DBB) scaffold. The release profile of BMP-2 indicated an initial burst release followed by a more even sustained release. An in vitro bioactivity assay revealed that the encapsulated growth factor was biologically active. The cell culture assay suggest that the excellent biocompatibility of the DBB- BMP-2/CS. Therefore, this novel microsphere scaffold system can be effectively used in current tissue engineering applications.
- 15 April 2015
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 14 (1) , 33
Open AccessPorous deproteinized bovine bone scaffold with three-dimensional localized drug delivery system using chitosan microspheres
Bone substation grafts, such as hydroxyapatite (HA) and tricalciumphosphate (TCP), have been extensively used in clinical applications, but evidence suggests that they offer poor osteoinductive properties compared to allografts and autografts. In order to increase bone growth with such grafts, Bone Morphogenetic Protein 2 (BMP-2) was incorporated into a three dimensional reservoir. The purpose of the present study was to develop a novel drug delivery system which is capable of controlled release of BMP-2. DBB were prepared from bovine cancellous bone harvested from fetal bovine femur or tibia and then sinting at 1000°C. BMP-2-loaded chitosan (CS) microspheres were fabricated by cross-linking. Then the treated DBB powders were blended with chitosan microspheres solution. Finally, the composites were lyophilized with a freeze dryer to obtain the DBB/CMs scaffolds. X-ray diffractor (XRD), scanning electron microscopy (SEM) and Fourier transform infrared (FT-IR) were used to characterize the sample. The quantification of the delivery profile of BMP-2 was determined using an enzyme-linked immunosorbent assay (ELISA) kit. The in vitro assays were to characterize the biocompatibility of this composite. In this study, BMP-2/Chitosan (CS) microspheres were successively loaded onto a deproteinized bovine bone (DBB) scaffold. The release profile of BMP-2 indicated an initial burst release followed by a more even sustained release. An in vitro bioactivity assay revealed that the encapsulated growth factor was biologically active. The cell culture assay suggest that the excellent biocompatibility of the DBB- BMP-2/CS. Therefore, this novel microsphere scaffold system can be effectively used in current tissue engineering applications.